"Pulse Therapy, Drug" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of high doses of pharmaceuticals over short periods of time.
| Descriptor ID |
D020551
|
| MeSH Number(s) |
E02.319.283.600
|
| Concept/Terms |
Pulse Therapy, Drug- Pulse Therapy, Drug
- Drug Pulse Therapies
- Pulse Therapies, Drug
- Therapies, Drug Pulse
- Therapy, Drug Pulse
- Pulse Drug Therapy
- Drug Therapies, Pulse
- Drug Therapy, Pulse
- Pulse Drug Therapies
- Therapies, Pulse Drug
- Therapy, Pulse Drug
- Drug Pulse Therapy
|
Below are MeSH descriptors whose meaning is more general than "Pulse Therapy, Drug".
Below are MeSH descriptors whose meaning is more specific than "Pulse Therapy, Drug".
This graph shows the total number of publications written about "Pulse Therapy, Drug" by people in this website by year, and whether "Pulse Therapy, Drug" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pulse Therapy, Drug" by people in Profiles.
-
Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review. Pediatr Rheumatol Online J. 2022 Feb 22; 20(1):16.
-
What's in a name? Surv Ophthalmol. 2016 Jan-Feb; 61(1):95-101.
-
Neglected tropical skin diseases: their global elimination through integrated mass drug administration? JAMA Dermatol. 2014 May; 150(5):481-2.
-
Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy. Pediatr Nephrol. 2007 Jul; 22(7):981-6.
-
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. J Clin Oncol. 2004 Dec 01; 22(23):4762-71.
-
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015). J Clin Oncol. 2004 Dec 01; 22(23):4804-9.
-
Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation. Bone Marrow Transplant. 2000 Sep; 26(5):573-6.